FRCA Notes


Elective Open AAA Repair


  • The aim of AAA repair, be it open or via EVAR, is to exclude the weak, aneurysmal segment from the circulation using a synthetic graft
  • Open repair is generally offered to younger, fitter patients with a long life expectancy, or those whose anatomy is unsuitable for EVAR

  • Access is usually transperitoneal via a midline laparotomy, which is quick and gives good exposure
  • A left retroperitoneal (flank) approach is an alternative, often reserved for a hostile abdomen or complex aneurysms

  • Heparin is given, and the aorta is cross-clamped above the aneurysm and the iliac arteries clamped below
    • The clamp is usually infra-renal, but juxta- and supra-renal aneurysms need a supra-renal or supra-coeliac clamp, with much greater physiological consequences
    • Clamping can embolise atheromatous plaque

  • The sac is opened, back-bleeding lumbar arteries are oversewn and the graft is sutured to the aorta at each end
    • Grafts may be straight 'tubes' or bifurcated 'trousers'
    • Flow to at least one internal iliac artery is preserved to reduce the risk of buttock claudication and colonic ischaemia
  • The sac is closed over the graft to separate it from the bowel

  • The main goal is to stratify and minimise the risk of a high-risk procedure, and to inform shared decision-making in the vascular MDT

History and examination

  • Coronary artery disease is the leading cause of morbidity and mortality after AAA repair; 70% of patients undergoing repair have it
  • Other common comorbidities increasing risk include cerebrovascular disease, renal impairment, COPD and diabetes
  • Functional capacity (e.g. METs) and frailty; frailty is associated with a five-fold increase in 30-day mortality after AAA repair
  • Medication review, particularly antiplatelets and anticoagulants

Investigations

  • Bloods: FBC | U&E and eGFR | Clotting | Albumin | Group and cross-match (6 units in our local vascular centre)
  • ECG
  • Transthoracic echo.
  • Objective functional assessment e.g. CPET
    • The VASGBI recommend objective assessment of functional capacity, with CPET where available, and it is widely used in UK practice
    • By contrast, the ESVS (2024) advise against routine CPET, coronary angiography or revascularisation in stable coronary disease, and against routine spirometry or CXR
    • The ESVS do recommend that patients with poor functional capacity (<4 METs) or active cardiac conditions (e.g. unstable angina, decompensated heart failure, severe valvular disease, significant arrhythmia) need cardiology work-up and optimisation
  • Carotid imaging only if there are symptoms of carotid disease; a recently symptomatic 50 - 99% stenosis should be treated first
  • CT angiography for surgical planning

Risk assessment

  • A number of risk prediction tools are available e.g. the Glasgow Aneurysm Score, V-POSSUM, the British Aneurysm Repair score and Carlisle's calculator (he has a word or two to say about risk prediction models)
  • NICE (2020) recommend using...  none of them, owing to a lack of "high enough predictive accuracy at predicting postoperative outcomes"
  • Patients could be stratified by predicted operative mortality into low (1 - 3%), moderate (3 - 5%) and high (5 - 10%) risk groups

Optimisation

  • Smoking cessation; this reduces respiratory complications and 1-year mortality after both open repair and EVAR
  • Start a statin, ideally at least 4 weeks before surgery, and continue it indefinitely
  • Continue aspirin (or clopidogrel) monotherapy; dual antiplatelet therapy and oral anticoagulants should be avoided peri-operatively where possible, which may involve liaison with Cardiology
  • Continue β-blockers if already taking, but do not start them pre-operatively
  • Control blood pressure
  • Treat anaemia
  • Optimise COPD to reduce the risk of post-operative pulmonary complications
  • Correct malnutrition; the ESVS use an albumin <28g/L as a threshold for pre-operative correction
  • Prehabilitation may modestly reduce cardiac and renal complications, though the evidence is of low certainty

Monitoring and access

  • AAGBI monitoring, with 5-lead ECG or the CM5 configuration as they are more sensitive for detecting myocardial ischaemia
  • Arterial line and central line
  • Large-bore IV access, with a rapid infuser and warmer available
  • Temperature monitoring and active warming; normothermia aids haemostasis, although lower body warming should be avoided while the clamp is on
  • Urinary catheter
  • Cardiac output monitoring e.g. oesophageal doppler may be unreliable while the aorta is clamped, and pulse contour analysis is not fully validated in this setting

Anaesthetic technique

  • A thoracic epidural is commonly sited before induction for intra- and post-operative analgesia
    • It is often not loaded until after clamp release and haemostasis, as sympathetic blockade may worsen declamping hypotension
    • Rectus sheath or wound catheters are an alternative; the ESVS rate both options equally
  • Induction and maintenance are as per routine practice; propofol/remifentanil TCI with pEEG monitoring is preferred in my trust
  • Prophylactic antibiotics

  • Communicate with the surgeons ahead of both clamp application and release; typical targets are:
    • Systolic BP ~100mmHg immediately before clamp application, in anticipation of the hypertension that follows
    • Systolic BP ~130mmHg immediately before clamp release, in anticipation of declamping hypotension
  • The management of each phase is covered on the aortic cross-clamp physiology page

Clotting, bleeding and fluid therapy

  • IV heparin (50 - 100 IU/kg; e.g. 5,000 IU for the fictional 70kg patient) is given before clamping to prevent thrombosis from stasis distal to the clamp
  • Targeting an ACT of 2 - 2.5× baseline ± protamine reversal is described, although this is not current practice in my institution

  • Cell salvage should be used
  • As these patients have significant cardiovascular disease, a transfusion threshold of ~80g/L is reasonable
  • Other blood products should be guided by viscoelastic haemostatic assays

  • Fluid loading before clamp release helps reduce declamping hypotension; this can be titrated to stroke volume or CVP

Intra-operative complications

  • The big worry is myocardial ischaemia or infarction
  • Acute LV failure and arrhythmias
  • Major haemorrhage
  • Distal embolism and limb ischaemia

  • All patients should go to a critical care (HDU or ICU) setting
  • Analgesia via the thoracic epidural or rectus sheath catheters, plus simple analgesics and opioids as needed
  • Regular lower limb neurovascular observations
  • An ERAS-style approach of early feeding, mobilisation, physiotherapy and VTE prophylaxis
  • Continue statin, antiplatelet and antihypertensive therapy lifelong

Post-operative complications

  • Cardiac: myocardial infarction, heart failure and arrhythmias
  • Respiratory: atelectasis, pneumonia and respiratory failure
  • Renal: AKI
  • Gastrointestinal: ileus and colonic ischaemia
  • Bleeding, graft thrombosis and limb ischaemia
  • If clamping was supra-coeliac; hepatic dysfunction and spinal cord ischaemia
  • Late: incisional hernia, graft infection and sexual dysfunction

  • A European Society for Vascular Surgery report (2008) showed the UK mortality rate after open AAA repair was the highest in Europe and Australasia (7.9% vs. 3.5%)
  • The AAA Quality Improvement Programme (AAA-QIP) was developed in response, alongside centralisation of vascular services
  • Mortality has fallen significantly as a result; overall elective AAA repair mortality was 2.4% in 2012

Previous: EVAR  |  Next: Ruptured AAA